|
"huang chung feng"的相關文件
顯示項目 36-53 / 53 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T05:02:40Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei, DJ;Hsu, HC;Lee, PH;Jeng, YM;Pu, YS;Chen, CN;Lee, YC;Chou, WC;Chang, CJ;Ni, YH;Chang, MH.; Tsuei, D.-J. and Hsu, H.-C. and Lee, P.-H. and Jeng, Y.-M. and Pu, Y.-S. and Chen, C.-N. and Lee, Y.-C. and Chou, W.-C. and Chang, C.-J. and Ni, Y.-H. and Chang, M.-H.; Liu, Chen-Hua; Tsuei, DJ; PO-HUANG LEE; Hsu, HC; Huang, Chung-Feng; MEI-HWEI CHANG; Lee, PH; Liu, Chun-Jen; CHIUNG-NIEN CHEN; YUNG-MING JENG; Dai, Chia-Yen; Jeng, YM; Yen-Hsuan Ni; Huang, Jee-Fu; Pu, YS; Chen, CN; Lin, Jou-Wei; YEONG-SHIAU PU; Lee, YC; Liang, Cheng-Chao; Chou, WC; Yang, Sheng-Shun; Lin, Chih-Lin; Chang, CJ; Su, Tung-Hung; Ni, YH; Yang, Hung-Chih; Chang, MH.; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立交通大學 |
2018-08-21T05:53:33Z |
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2018-08-21T05:53:04Z |
Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments
|
Huang, Chung-Feng; Yu, Ming-Lung |
| 嘉南藥理大學 |
2016-04 |
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
|
Wu, Kuan-Ta; Kuo, Po-Lin; Su, Shih-Bin; Chen, Yi-Yu; Yeh, Ming-Lum; Huang, Ching-I; Yang, Jeng-Fu; Lin, Chia-I; Hsieh, Meng-Hsuan; Hsieh, Ming-Yen; Huang, Chung-Feng; Lin, Wen-Yi; Yu, Ming-Lung; Dai, Chia-Yen; Wang, Hsien-Yi |
| 國立成功大學 |
2015-09-14 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人 |
| 嘉南藥理大學 |
2014-02 |
High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
|
Yu, Ming-Lung; Dai, Chia-Yen; Huang, Chung-Feng; Lee, Jia-Jung; Yeh, Ming-Lun; Yeh, Shih-Meng; Kuo, Hsing-Tao; Huang, Jee-Fu; Chang, Jer-Ming; Chen, Hung-Chun; Juo, Suh-Hang Hank; Hwang, Shang-Jyh; Chuang, Wan-Long |
| 嘉南藥理大學 |
2014 |
Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
|
Chang, Jer-Ming; Huang, Chung-Feng; Chen, Szu-Chia; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Jee-Fu; Kuo, Hsing-Tao; Chuang, Wan-Long; Yu, Ming-Lung; Hwang, Shang-Jyh; Chen, Hung-Chun |
| 國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2013 |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng; Yu, Ming-Lung; Kao, Jia-Horng; Tseng, Tai-Chung; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Liu, Chen-Hua; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2013 |
Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 嘉南藥理大學 |
2012-05 |
Erratum to:"Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin"[J Hepatol 2012;56:34–40]
|
Huang, Chung-Feng; Huan, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 嘉南藥理大學 |
2012 |
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
|
Huang, Chung-Feng; Huang, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 國立臺灣大學 |
2012 |
Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 高雄醫學大學 |
2009 |
長效型干擾素合併雷巴威靈在慢性C型肝炎老人患者的療效及安全性研究
|
黃釧峰; Huang, Chung-Feng |
顯示項目 36-53 / 53 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
